Daniel Loeb Baxter International Inc Transaction History

Third Point LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$78.33 - $90.73 $313 Million - $363 Million	-4,000,000 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$78.66 - $94.14 $596 Million - $714 Million	-7,580,000 Reduced 65.46%	4,000,000 $344 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $424 Million - $552 Million	-5,920,000 Reduced 33.83%	11,580,000 $940 Million
Q4 2019 Feb 13, 2020	BUY	$76.7 - $88.45 $49.9 Million - $57.5 Million	650,000 Added 3.86%	17,500,000 $1.46 Billion
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $501 Million - $552 Million	-6,150,000 Reduced 26.74%	16,850,000 $1.47 Billion
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $367 Million - $412 Million	-5,000,000 Reduced 17.86%	23,000,000 $1.88 Billion
Q4 2018 Feb 08, 2019	SELL	$61.45 - $77.8 $492 Million - $622 Million	-8,000,000 Reduced 22.22%	28,000,000 $1.84 Billion
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $307 Million - $330 Million	-5,000,000 Reduced 12.2%	36,000,000 $2.33 Billion
Q3 2017 Nov 09, 2017	BUY	$59.5 - $64.61 $2.44 Billion - $2.65 Billion	41,000,000	41,000,000 $2.57 Billion

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Third Point LLC, based on Form 13F filings with the SEC.

Stay updated on Third Point LLC and Daniel Loeb with notifications on news.